Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction

CMAJ. Canadian Medical Association Journal

Volumn 179, Issue 9, 2008, Pages 895-900

  Austin, Peter C ^a,f   Tu, Jack V ^a,b,c   Ko, Dennis T ^a,b,c   Alter, David A ^a,d,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e TORONTO REHABILITATION INSTITUTE   (Canada)

^f INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; AGED; ARTICLE; COHORT ANALYSIS; DATA BASE; ELDERLY CARE; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE QUALITY; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRESCRIPTION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TEACHING HOSPITAL;

EID: 54349090334     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.071481     Document Type: Article

References (21)

1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ 2002;324:71-86.
2. Freemantle N, Cleland J, Young P, et al. Beta blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 1999;18:1730-7.
3. Flather MD, Yusuf S, Kober L, et al. Long-term ACE inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. Lancet 2000;355:1575-81.
4. LaRosa JC, He J, Vupputuri S. Effects of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 1999;282:2340-6.
5. Smith J, Channer KS. Increasing prescription of drugs for secondary prevention after myocardial infarction. BMJ 1995;311:917-8.
6. Soumerai SB, McLaughlin TJ, Spiegelman D, et al. Adverse outcomes of underuse of β-blockers in elderly survivors of acute myocardial infarction. JAMA 1997;277:115-21.
7. Gurwitz JH, Goldberg RJ, Chen Z, et al. β-blocker therapy in acute myocardial infarction: Evidence for underutilization in the elderly. Am J Med 1992;93:605-10.
8. Brand DA, Newcomer LN, Freiburger A, et al. Cardiologists' practice compared with practice guidelines: Use of beta-blockade after acute myocardial infarction. J Am Coll Cardiol 1995;26:1432-6.
9. Barron HV, Michaels AD, Maynard C, et al. Use of antiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. J Am Coll Cardiol 1998;32:360-7.
10. Krumholz HM, Radford MJ, Wang Y, et al. National use and effectiveness of β-blockers for the treatment of elderly patients with acute myocardial infarction. JAMA 1998;280:623-9.
11. Rochon PA, Anderson GM, Tu JV, et al. Use of β-blocker therapy in older patients after acute myocardial infarction in Ontario. CMAJ 1999;161:1403-8.
12. Dwamena FC, El-Tamimi H, Watson RE, et al. Kupersmith J for the Michigan State University Inter-Institutional Collaborative Heart (MICH) Study Group. Clin Cardiol 2000;23:341-6.
13. Tu JV, Naylor CD, Austin P. Temporal changes in the outcomes of acute myocardial infarction in Ontario, 1992-96. CMAJ 1999;161:1257-61.
14. Tu JV, Austin P, Naylor CD, et al. Acute myocardial infarction outcomes in Ontario. In: Naylor CD, Slaughter PM, editors. Cardiovascular health and services in Ontario: An ICES atlas. Toronto (ON): Institute for Clinical Evaluative Sciences; 1999. p. 83-110.
15. Austin PC, Daly PA, Tu JV. A multicenter study of the coding accuracy of hospital discharge administrative data for cardiac care unit patients in Ontario. Am Heart J 2002;144:290-6.
16. Austin PC, Goel V, van Walraven C. An Introduction to Multilevel Regression Models. Can J Public Health 2001;92:150-4.
17. Tu JV, Austin PC, Walld R, et al. Development and validation of the Ontario acute myocardial mortality prediction rules. J Am Coll Cardiol 2001;37:992-7.
18. Austin PC, Tu JV, Alter DA. Comparing hierarchical modeling with traditional logistic regression analysis among patients hospitalized with acute myocardial infarction: Should we be analyzing cardiovascular outcomes data differently? Am Heart J 2003;145:27-35.
19. Masoudi FA, Foody JM, Havrenek EP, et al. Trends in acute myocardial infarction in 4 US states between 1992 and 2001: Clinical characteristics, quality of care, and outcomes. Circulation 2006;114:2806-14.
20. Bradley EH, Holmboe ES, Mattera JA, et al. A qualitative study of increasing β-blocker use after myocardial infarction: Why do some hospitals succeed? JAMA 2001;285:2604-11.
21. Tu JV, Austin P, Rochon P, et al. Secondary prevention after acute myocardial infarction, congestive heart failure and coronary artery bypass graft surgery in Ontario. In: Naylor CD, Slaughter PM, editors. Cardiovascular Health and Services in Ontario: An ICES Atlas. Toronto (ON): Institute for Clinical Evaluative Sciences; 1999. p.199-238.